Ellis Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.42M | Buy |
4,047
+602
| +17% | +$215K | 0.25% | 88 |
|
|
2025
Q4 | $1.13M | Buy |
3,445
+620
| +22% | +$197K | 0.2% | 97 |
|
|
2025
Q3 | $797K | Sell |
2,825
-164
| -5% | -$47.6K | 0.14% | 118 |
|
|
2025
Q2 | $835K | Buy |
2,989
+20
| +0.7% | +$5.67K | 0.16% | 107 |
|
|
2025
Q1 | $925K | Sell |
2,969
-316
| -10% | -$93.3K | 0.19% | 102 |
|
|
2024
Q4 | $856K | Buy |
3,285
+16
| +0.5% | +$4.75K | 0.17% | 104 |
|
|
2024
Q3 | $1.05M | Sell |
3,269
-215
| -6% | -$70.3K | 0.21% | 95 |
|
|
2024
Q2 | $1.09M | Buy |
3,484
+35
| +1% | +$10.3K | 0.23% | 86 |
|
|
2024
Q1 | $981K | Buy |
3,449
+262
| +8% | +$76.7K | 0.21% | 90 |
|
|
2023
Q4 | $918K | Buy |
3,187
+29
| +0.9% | +$7.9K | 0.21% | 90 |
|
|
2023
Q3 | $849K | Buy |
3,158
+16
| +0.5% | +$3.99K | 0.22% | 93 |
|
|
2023
Q2 | $698K | Buy |
3,142
+51
| +2% | +$11.8K | 0.17% | 104 |
|
|
2023
Q1 | $747K | Buy |
3,091
+16
| +0.5% | +$3.93K | 0.19% | 101 |
|
|
2022
Q4 | $808K | Sell |
3,075
-14
| -0.5% | -$3.75K | 0.22% | 95 |
|
|
2022
Q3 | $696K | Buy |
3,089
+14
| +0.5% | +$3.39K | 0.19% | 99 |
|
|
2022
Q2 | $748K | Buy |
3,075
+7
| +0.2% | +$1.72K | 0.2% | 94 |
|
|
2022
Q1 | $742K | Buy |
3,068
+137
| +5% | +$31.5K | 0.17% | 103 |
|
|
2021
Q4 | $659K | Buy |
2,931
+1,438
| +96% | +$303K | 0.15% | 115 |
|
|
2021
Q3 | $317K | Buy |
1,493
+23
| +2% | +$5.29K | 0.08% | 164 |
|
|
2021
Q2 | $358K | Sell |
1,470
-767
| -34% | -$189K | 0.09% | 146 |
|
|
2021
Q1 | $557K | Sell |
2,237
-1,024
| -31% | -$244K | 0.16% | 114 |
|
|
2020
Q4 | $750K | Buy |
3,261
+2
| +0.1% | +$461 | 0.23% | 85 |
|
|
2020
Q3 | $828K | Sell |
3,259
-26
| -0.8% | -$6.44K | 0.29% | 66 |
|
|
2020
Q2 | $838K | Buy |
3,285
+68
| +2% | +$15.5K | 0.31% | 59 |
|
|
2020
Q1 | $636K | Buy |
3,217
+1
| +0% | +$218 | 0.3% | 62 |
|
|
2019
Q4 | $772K | Buy |
3,216
+1
| +0% | +$220 | 0.26% | 73 |
|
|
2019
Q3 | $621K | Buy |
3,215
+25
| +0.8% | +$4.8K | 0.23% | 87 |
|
|
2019
Q2 | $594K | Buy |
3,190
+1
| +0% | +$179 | 0.22% | 87 |
|
|
2019
Q1 | $611K | Buy |
3,189
+1
| +0% | +$191 | 0.25% | 86 |
|
|
2018
Q4 | $620K | Buy |
+3,188
| New | +$622K | 0.28% | 77 |
|
Other funds holding AMGN
VCM
VPM
Ellis Investment Partners's AMGN Position: Q1 2026 in Review
Ellis Investment Partners increased its Amgen (AMGN) stake by 17% in Q1 2026, buying an estimated $215K and bringing the position to 4,047 shares worth $1.42M. The position accounts for 0.25% of the portfolio, ranked #88.
Ellis Investment Partners first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Ellis Investment Partners held 4,047 shares of Amgen worth $1.42M as of Q1 2026.
- Ellis Investment Partners bought 602 Amgen shares in Q1 2026, an estimated $215K.
- Amgen made up 0.25% of Ellis Investment Partners's portfolio in Q1 2026, its #88 holding.
- Ellis Investment Partners first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Ellis Investment Partners's 13F filing for Q1 2026, filed 12 May 2026.